The problem with policy via anecdote is that the inevitable horror stories among any health care system that attempts to serve a population of 300 million people will exercise disproportionate weight over statistical analysis. This is because the math literate speak quantitative and the non-math literate speak qualitative. So take into account not individual horror stories but systematic restrictions of care when the government becomes involved in dictating what is best practice , it is interesting to look at Great Britain where, as noted in WSJ , if you are going blind due to treatable macular degeneration, the government will only approve treatment for one eye: In 2007, the board restricted access to two drugs for macular degeneration, a cause of blindness. The drug Macugen was blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, restricting it to about one in five sufferers. Even then, the drug was only approved for use in on...